Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antineoplastic Protocols”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Early research (Phase 1)Ended earlyNCT00651365
What this trial is testing

A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.

Who this might be right for
Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14
Not applicableStudy completedNCT02777697
What this trial is testing

Cancer Chronic Pain Predicted by Emotional and Cognitive Status

Who this might be right for
Chronic PainCancer
University Hospital, Clermont-Ferrand 89
Early research (Phase 1)Study completedNCT00676299
What this trial is testing

A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.

Who this might be right for
Protein Kinase InhibitorsAntineoplastic ProtocolsClinical Trial, Phase 1+4 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 19
Not applicableLooking for participantsNCT07467434
What this trial is testing

FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases

Who this might be right for
Rectal CancerSynchronous Liver MetastasesAntineoplastic Combined Chemotherapy Protocols+1 more
Assistance Publique - Hôpitaux de Paris 550
Early research (Phase 1)Study completedNCT00080041
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+1 more
Pharmacyclics LLC. 20
Not applicableUnknownNCT06621459
What this trial is testing

Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

Who this might be right for
Brest CancerAbemaciclibAdjuvant Therapy+2 more
University Hospital, Brest 30
Testing effectiveness (Phase 2)UnknownNCT02953184
What this trial is testing

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Who this might be right for
Antineoplastic Combined Chemotherapy Protocols
Jilin University 160
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Testing effectiveness (Phase 2)Ended earlyNCT00351858
What this trial is testing

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsBreast Cancer
Neovii Biotech 40
Large-scale testing (Phase 3)Study completedNCT00069745
What this trial is testing

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Who this might be right for
Prostate CancerHormone Refractory Prostate Cancer
Agennix
Post-approval studies (Phase 4)Study completedNCT00380965
What this trial is testing

Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy

Who this might be right for
Peripheral NeuropathyAntineoplastic Combined Chemotherapy Protocols
NEMA Research, Inc. 23
Early research (Phase 1)Study completedNCT00925743
What this trial is testing

Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Who this might be right for
Solid Cancer
Sanofi 76
Large-scale testing (Phase 3)Study completedNCT00822809
What this trial is testing

CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers

Who this might be right for
CancerNeoplasmsCarcinoma+1 more
Neovii Biotech 230
Not applicableStudy completedNCT01540045
What this trial is testing

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerDysgeusiaTaste Disorders+2 more
Instituto Nacional de Cancerologia de Mexico 40
Testing effectiveness (Phase 2)Ended earlyNCT00452140
What this trial is testing

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Neovii Biotech 40
Large-scale testing (Phase 3)Study completedNCT01052844
What this trial is testing

Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy

Who this might be right for
VomitingCisplatin Adverse Reaction
Faculdade de Medicina do ABC 80
Not applicableLooking for participantsNCT06381726
What this trial is testing

Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life

Who this might be right for
GliomaGlioma, Malignant
University of Milan 400
Testing effectiveness (Phase 2)UnknownNCT03651375
What this trial is testing

Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall

Who this might be right for
SarcomaFibrosarcomaLeiomyosarcoma+14 more
Maria Sklodowska-Curie National Research Institute of Oncology 46
Testing effectiveness (Phase 2)Ended earlyNCT00522457
What this trial is testing

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Neovii Biotech 19